NCT07794072

Brief Summary

The goal of this observational study is to investigate digital patient engagement and its psychosocial correlates and potential predictors among adults aged 18-85 years with neurological disorders who are undergoing technology-supported neurorehabilitation using robotic systems for upper-limb training and/or virtual reality-based technologies. Specifically, the study will examine the roles of hope and the quality of the patient-healthcare professional relationship as the potential predictors of engagement with rehabilitation technologies. It will also explore the contribution of disease-management self-efficacy, technology anxiety, and sociodemographic, clinical, functional, and rehabilitation-related characteristics. Finally, the study will examine whether digital patient engagement predicts the perceived psychosocial impact of rehabilitation technologies, behavioural intention to continue using them, and overall satisfaction with the rehabilitation pathway. Participants will:

  • continue their standard neurorehabilitation pathway without any modification to routine clinical procedures;
  • complete a computerized self-report questionnaire via the Qualtrics digital platform at a single time point after completing at least three rehabilitation sessions using the technologies under study. No experimental intervention, comparison group, or follow-up assessment is planned.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
129

participants targeted

Target at P50-P75 for all trials

Timeline
9mo left

Started Oct 2026

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Oct 2026Jul 2027

First Submitted

Initial submission to the registry

August 26, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 31, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

September 15, 2026

Status Verified

June 1, 2026

Enrollment Period

9 months

First QC Date

August 26, 2026

Last Update Submit

September 10, 2026

Conditions

Keywords

NeurorehabilitationDigital patient engagementPsychosocial factorsRobotic rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Digital patient engagement score assessed using the TWente Engagement with Ehealth Technologies Scale after completion of at least 3 rehabilitation sessions with the technologies

    Digital patient engagement in the use of neurorehabilitation technologies will be measured using the TWente Engagement with Ehealth Technologies Scale (TWEETS), a 9-item self-report scale assessing cognitive, emotional, and behavioral engagement with eHealth technologies. Items are rated on a 4-point Likert scale from 1 = strongly disagree to 4 = strongly agree. A total score is calculated by summing the 9 items, with possible scores ranging from 9 to 36. Higher scores indicate higher digital patient engagement. "Not applicable" responses, if selected, are treated as missing and handled according to the pre-specified scoring plan.

    At baseline, single assessment (Day 1)

Secondary Outcomes (3)

  • Overall satisfaction with rehabilitation score assessed using the Overall Satisfaction with Rehabilitation Scale after completion of at least 3 rehabilitation sessions with the technologies

    At baseline, single assessment (Day 1)

  • Behavioral intention to continue using rehabilitation technologies score assessed using adapted UTAUT items after completion of at least 3 rehabilitation sessions with the technologies

    At baseline, single assessment (Day 1)

  • Perceived psychosocial impact of rehabilitation technologies score assessed using the Psychosocial Impact of Assistive Devices Scale short form after completion of at least 3 rehabilitation sessions with the technologies

    At baseline, single assessment (Day 1)

Study Arms (1)

Patients Undergoing Technology-Supported Neurorehabilitation

Adult patients with neurological disorders undergoing standard neurorehabilitation involving upper-limb robotic rehabilitation systems and/or virtual reality-based rehabilitation technologies at participating ICS Maugeri centres.

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population is adult patients who, from the study start date at each participating ICS Maugeri centre, are enrolled under ordinary inpatient admission, simple outpatient care, or MAC (MacroattivitĂ  Ambulatoriale Complessa; Complex Outpatient Macro-Activity), in a neurorehabilitation programme involving the support and use of robotic systems for upper-limb rehabilitation training (Gloreha BTL Robotics, Motore Humanware) and/or virtual reality-based rehabilitation technologies (VRRS Khymeia, Prokin Tecnobody).

You may qualify if:

  • Aged between 18 and 85 years.
  • Diagnosed with one of the following neurological conditions: stroke, Parkinson's disease, ataxia, motor neuron disease, spinal cord injury, traumatic brain injury, or post-neurosurgical neurological outcomes.
  • Have completed at least three rehabilitation sessions using the technologies under study, representing the minimum exposure required for participants to become sufficiently familiar with the technology and to provide informed feedback on their experience of use.
  • Have adequate cognitive functioning, defined as the ability to understand study-related information, provide informed consent, and reliably complete the planned assessment measures, as determined by the clinical team during routine clinical evaluation.
  • Have sufficient proficiency in Italian to understand the study information and complete the assessment measures reliably.
  • Can use the digital tools required for data collection, e.g., a tablet, either independently or with compensatory aids and/or assistance from the data collection staff.

You may not qualify if:

  • Diagnosis of an acute or non-stabilized psychiatric disorder, such as an active psychotic episode or a depressive episode with severe symptoms, that may interfere with informed participation in the study.
  • Severe uncompensated sensory impairment, such as severe visual or hearing impairment, that prevents the use of the digital tools required for data collection.
  • Motor impairment that prevents interaction with a tablet, even with compensatory aids and/or assistance from the data collection staff.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

ICS Maugeri IRCCS - Istituto Scientifico di Milano

Milan, 20138, Italy

Location

ICS Maugeri IRCCS - Istituto Scientifico di Montescano

Montescano, Italy

Location

ICS Maugeri IRCCS - Istituto Scientifico di Pavia

Pavia, Italy

Location

Related Publications (20)

  • Klaic M, Galea MP. Using the Technology Acceptance Model to Identify Factors That Predict Likelihood to Adopt Tele-Neurorehabilitation. Front Neurol. 2020 Dec 2;11:580832. doi: 10.3389/fneur.2020.580832. eCollection 2020.

    PMID: 33343488BACKGROUND
  • Warraich Z, Kleim JA. Neural plasticity: the biological substrate for neurorehabilitation. PM R. 2010 Dec;2(12 Suppl 2):S208-19. doi: 10.1016/j.pmrj.2010.10.016.

    PMID: 21172683BACKGROUND
  • Danzl MM, Etter NM, Andreatta RD, Kitzman PH. Facilitating neurorehabilitation through principles of engagement. J Allied Health. 2012 Spring;41(1):35-41.

    PMID: 22544406BACKGROUND
  • Kelders SM, Kip H, Greeff J. Psychometric Evaluation of the TWente Engagement with Ehealth Technologies Scale (TWEETS): Evaluation Study. J Med Internet Res. 2020 Oct 9;22(10):e17757. doi: 10.2196/17757.

    PMID: 33021487BACKGROUND
  • Di Nitto M, Durante A, Torino F, Bolgeo T, Damico V, Ghizzardi G, Zerulo SR, Alvaro R, Vellone E, Biagioli V. Validity and Reliability of the Self-Care of Chronic Illness Inventory and Self-Care Self-Efficacy Scale in Patients Living With Cancer. J Adv Nurs. 2025 Dec;81(12):8620-8632. doi: 10.1111/jan.16823. Epub 2025 Feb 19.

    PMID: 39968728BACKGROUND
  • Ritter PL, Lorig K. The English and Spanish Self-Efficacy to Manage Chronic Disease Scale measures were validated using multiple studies. J Clin Epidemiol. 2014 Nov;67(11):1265-73. doi: 10.1016/j.jclinepi.2014.06.009. Epub 2014 Aug 3.

    PMID: 25091546BACKGROUND
  • Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P; ISPOR Task Force for Translation and Cultural Adaptation. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005 Mar-Apr;8(2):94-104. doi: 10.1111/j.1524-4733.2005.04054.x.

    PMID: 15804318BACKGROUND
  • Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91. doi: 10.1097/00007632-200012150-00014. No abstract available.

    PMID: 11124735BACKGROUND
  • Fraser L, Burnell M, Salter LC, Fourkala EO, Kalsi J, Ryan A, Gessler S, Gidron Y, Steptoe A, Menon U. Identifying hopelessness in population research: a validation study of two brief measures of hopelessness. BMJ Open. 2014 May 30;4(5):e005093. doi: 10.1136/bmjopen-2014-005093.

    PMID: 24879829BACKGROUND
  • Andrich, R., Pedroni, F., & Vanni, G. (2003). Psychosocial impact of assistive devices: Italian localization of the PIADS instrument. Assistive Technology-Shaping the Future, GM Craddock, LP McCormack, RB Reilly, and HTP Knops, Eds, 917-921.

    BACKGROUND
  • Yang, C., Wu, C. F., Wang, J., Chen, W. C., Chang, H., & Xu, D. D. (2024). A study on the intention of upper limb hemiplegic patients to use interactive gaming devices for hand rehabilitation. The Design Journal, 27(3), 470-492. https://doi.org/10.1080/14606925.2024.2334139

    BACKGROUND
  • Venkatesh, V., Morris, M. G., Davis, G. B., & Davis, F. D. (2003). User Acceptance of Information Technology: Toward a Unified View. MIS Quarterly, 27(3), 425-478. https://doi.org/10.2307/30036540

    BACKGROUND
  • Cressman, J. M., & Dawson, K. A. (2011). Evaluation of the Use of Healing Imagery in Athletic Injury Rehabilitation. Journal of Imagery Research in Sport and Physical Activity, 6(1). https://doi.org/10.2202/1932-0191.1060

    BACKGROUND
  • Matamala-Gomez M, Maisto M, Montana JI, Mavrodiev PA, Baglio F, Rossetto F, Mantovani F, Riva G, Realdon O. The Role of Engagement in Teleneurorehabilitation: A Systematic Review. Front Neurol. 2020 May 6;11:354. doi: 10.3389/fneur.2020.00354. eCollection 2020.

    PMID: 32435227BACKGROUND
  • Zanatta F, Giardini A, Pierobon A, D'Addario M, Steca P. A systematic review on the usability of robotic and virtual reality devices in neuromotor rehabilitation: patients' and healthcare professionals' perspective. BMC Health Serv Res. 2022 Apr 20;22(1):523. doi: 10.1186/s12913-022-07821-w.

    PMID: 35443710BACKGROUND
  • Yu DS, De Maria M, Barbaranelli C, Vellone E, Matarese M, Ausili D, Rejane RE, Osokpo OH, Riegel B. Cross-cultural applicability of the Self-Care Self-Efficacy Scale in a multi-national study. J Adv Nurs. 2021 Feb;77(2):681-692. doi: 10.1111/jan.14617. Epub 2020 Dec 9.

    PMID: 33295675BACKGROUND
  • Wilson ML, Huggins-Manley AC, Ritzhaupt AD, Ruggles K. Development of the Abbreviated Technology Anxiety Scale (ATAS). Behav Res Methods. 2023 Jan;55(1):185-199. doi: 10.3758/s13428-022-01820-9. Epub 2022 Mar 25.

    PMID: 35338456BACKGROUND
  • Oltedal S, Garratt A, Bjertnaes O, Bjornsdottir M, Freil M, Sachs M. The NORPEQ patient experiences questionnaire: data quality, internal consistency and validity following a Norwegian inpatient survey. Scand J Public Health. 2007;35(5):540-7. doi: 10.1080/14034940701291724.

    PMID: 17852989BACKGROUND
  • Day H, Jutai J, Campbell KA. Development of a scale to measure the psychosocial impact of assistive devices: lessons learned and the road ahead. Disabil Rehabil. 2002 Jan 10-Feb 15;24(1-3):31-7. doi: 10.1080/09638280110066343.

    PMID: 11827152BACKGROUND
  • Rosa D, Villa G, Marcomini I, Nardin E, Gianfranceschi E, Faini A, Pengo MF, Bilo G, Croce A, Manara DF, Parati G. Psychometric Properties of the TWente Engagement with Ehealth Technologies Scale (TWEETS) Among Patients with Hypertension in Italy. High Blood Press Cardiovasc Prev. 2025 Jan;32(1):61-68. doi: 10.1007/s40292-024-00688-4. Epub 2024 Oct 29.

    PMID: 39472407BACKGROUND

MeSH Terms

Conditions

StrokeParkinson DiseaseMotor Neuron DiseaseSpinal Cord InjuriesBrain Injuries, TraumaticNervous System DiseasesAtaxia

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular DiseasesParkinsonian DisordersBasal Ganglia DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesNeuromuscular DiseasesSpinal Cord DiseasesTrauma, Nervous SystemWounds and InjuriesBrain InjuriesCraniocerebral TraumaDyskinesiasNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Patrizia Catellani, PhD in Social Psychology

    Catholic University, Italy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Patrizia Catellani, PhD in Social Psychology

CONTACT

Valentina Carfora, PhD in Social Psychology

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor

Study Record Dates

First Submitted

August 26, 2026

First Posted

August 31, 2026

Study Start

October 1, 2026

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2027

Last Updated

September 15, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because the study involves clinical and psychosocial data from a vulnerable neurological rehabilitation population. Data will be processed in pseudonymized/anonymized form, and access will be limited to authorized study personnel in accordance with the approved protocol and applicable data protection regulations.

Locations